BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 33120616)

  • 1. Modern treatment of retinoblastoma: A 2020 review.
    Ancona-Lezama D; Dalvin LA; Shields CL
    Indian J Ophthalmol; 2020 Nov; 68(11):2356-2365. PubMed ID: 33120616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
    Dalvin LA; Bas Z; Tadepalli S; Rao R; Vaidya S; Pacheco R; Shields CL
    J Pediatr Ophthalmol Strabismus; 2020 Jul; 57(4):224-234. PubMed ID: 32687206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of primarily treated group D retinoblastoma.
    Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ADVANCES IN THE TREATMENT OF RETINOBLASTOMA AT HADASSAH IN THE LAST THREE DECADES].
    Frenkel S; Weintraub M; Rot I; Shoshani N; Pe'er J
    Harefuah; 2018 Mar; 157(3):149-153. PubMed ID: 29582943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Retinoblastoma in 2015: Agreement and Disagreement.
    Abramson DH; Shields CL; Munier FL; Chantada GL
    JAMA Ophthalmol; 2015 Nov; 133(11):1341-7. PubMed ID: 26378747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Available approaches to retinoblastoma therapy--literature review].
    Morawski K; Kulig-Stochmal A; Drychowska-Jęmhorska JJ; Kuhicka-Trząska A; Romanowska-Dixon B
    Klin Oczna; 2015; 117(1):45-9. PubMed ID: 26349159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in the management of retinoblastoma.
    Shields CL; Shields JA
    J Pediatr Ophthalmol Strabismus; 1999; 36(1):8-18; quiz 35-6. PubMed ID: 9972509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current treatment of retinoblastoma.
    De Potter P
    Curr Opin Ophthalmol; 2002 Oct; 13(5):331-6. PubMed ID: 12218465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in Austria.
    Sovinz P; Urban C; Lackner H; Benesch M; Langmann G
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):22-30. PubMed ID: 16489522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuing challenges in the management of retinoblastoma with chemotherapy.
    Shields CL; Meadows AT; Leahey AM; Shields JA
    Retina; 2004 Dec; 24(6):849-62. PubMed ID: 15579981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoblastoma in Turkey: results from a tertiary care center in Ankara.
    Gündüz K; Köse K; Kurt RA; Süren E; Taçyildiz N; Dinçaslan H; Ünal E; Erden E; Heper AO
    J Pediatr Ophthalmol Strabismus; 2013; 50(5):296-303. PubMed ID: 23937863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoblastoma.
    Rao R; Honavar SG
    Indian J Pediatr; 2017 Dec; 84(12):937-944. PubMed ID: 28620731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
    Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and prognostic factors of chemoreduction combined with topical treatment for advanced intraocular retinoblastoma.
    Liu Y; Zhang X; Liu F; Wang KL
    Asian Pac J Cancer Prev; 2014; 15(18):7805-9. PubMed ID: 25292067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative treatment modalities in retinoblastoma.
    Chawla B; Jain A; Azad R
    Indian J Ophthalmol; 2013 Sep; 61(9):479-85. PubMed ID: 24104705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoblastoma - A comprehensive review, update and recent advances.
    Nag A; Khetan V
    Indian J Ophthalmol; 2024 Jun; 72(6):778-788. PubMed ID: 38804799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for retinoblastoma: a current topic.
    Finger PT; Czechonska G; Demirci H; Rausen A
    Drugs; 1999 Dec; 58(6):983-96. PubMed ID: 10651386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.